Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors Sharyn D. BakerRichard L. HeidemanClinton F. Stewart Topotecan, CSF Penetration, CSF Pharmacokinetics Pages: 195 - 202
A microcomputer program for calculating cell population doubling time in vitro and in vivo Jeffrey I. ZwickerRobert T. ProffittC. Patrick Reynolds Cell Growth Kinetics, Nude Mice, Microcomputer, Computer Software Pages: 203 - 210
Antitumor activity of treosulfan in human lung carcinomas P. Köpf-MaierG. Saß Treosulfan, Alkylating Agent, Antitumor Activity, Small-Cell Lung Carcinomas, Non-Small-Cell Lung Carcinomas Pages: 211 - 221
Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitro Ting-Chao ChouGlenys M. OtterFrancis M. Sirotnak Edatrexate, Taxol, Taxotere, Breast Cancer, Combination Treatment Pages: 222 - 228
Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside Alxandre HageboutrosGary R. HudesPeter J. O'Dwyer 5-Fluorouracil, Phosphonacetyl-L-Aspartate, b-Methylmercaptopurine Riboside, Combination Treatment, Pharmacokinetics Pages: 229 - 234
Multi-chemothermoimmunotherapy for human colon adenocarcinoma in vitro Jim KlostergaardM. Elena LerouxStephen P. Tomasovi Chemotherapy, TNF, Hyperthermia, Colon Adenocarcinoma, Multimodality Pages: 235 - 241
Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and-resistant medulloblastoma cell lines Qing DongNancy BullockHenry S. Friedman 4-Hydroperoxycyclophosphamide, c-myc, DNA Interstrand Crosslinks Pages: 242 - 246
Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation Gilles VassalSerge KoscielnyOlivier Hartmann Busulfan, Pharmacodynamics, Hepatic Veno-Occlusive Disease Pages: 247 - 253
Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer Karen HoffmanFrankie Ann HolmesGabriel N. Hortobagyi Tricyclic Nucleoside, Phosphate, Triciribine, Metastatic Breast Cancer, Hypertriglyceridemia, Hyperglycemia Pages: 254 - 258
5-fluorouracil metabolism and cytotoxicity after pre-treatment with methotrexate or thymidine in human hypopharynx and colon carcinoma xenografts: a19F-nuclear magnetic resonance spectroscopy study in vivo Robert Tausch-TremlFrank BaumgartPetra Köpf-Maier 19F-NMR Spectroscopy, 5-FU, Combined Treatment Modality Pages: 259 - 265
Evaluation of formulas using the serum creatinine level to calculate the optimal dosage of carboplatin Laurence J. C. van WarmerdamSjoerd RodenhuisJos H. Beijnen AUC, Carboplatin, Pharmacokinetics Pages: 266 - 270
Comparison of the antitumor activity of bryostatins 1, 5, and 8 Andrew S. KraftSteven WoodleyFred Wagner Bryostatin Analogs, Protein Kinase C, Tumor Necrosis Factor, Bryostatin Blood Levels Pages: 271 - 278
Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis Ting-Chang ChangFushing HsiehYoong-Kuei Soong Tropisetron, Metoclopramide Cocktail, Cisplatin-Induced Emesis Pages: 279 - 285
Effect of different mathematical methods on etoposide area under the curve estimations and pharmacodynamic response predictions Dayna L. McCauleyBert L. LumBranimir I. Sikic Etoposide, Pharmacokinetics, AUC Pages: 286 - 288
